Ventrus Biosciences (VTUS)

9.86 -0.25  -2.47%  Jun 01, 11:08AM Go Pro
Watch this stock
View Full Chart VTUS Price Chart

Key Stats

Market Cap 122.36M
Revenue Growth
Profit Margin
Earnings Yield
Dividend Yield 0.00%
Earnings Per Share TTM
PE Ratio
Price / Sales Ratio
52 Week High 17.28
52 Week Low 6.64
Beta
View Pro Ratings Details

YCharts Pro Ratings

Go Pro.
Learn More
  • Pro Value Score Go Pro
  • Pro Fundamental Score Go Pro
  • Pro Valuation from Historical Multiples Go Pro

News

May 31 $KERX solid volume pushing higher so far. $amrn $arna holding up. $vtus looking to add by ITradeforMe
May 30 $VTUS 7% with some volume.nice.. by ITradeforMe
May 30 Ventrus to Present at the Jefferies 2012 Global Healthcare Conference $VTUS http://stks.co/428w by ventrusbio
May 30 $AMRN Green Bio's $qcor $thld $arna $VTUS Catalysts trump Europe by ITradeforMe
May 30 UPDATE: Cantor Fitzgerald Raises PT to $30 on Ventrus Biosciences on Hemorrhoid Resul...
May 30 Ventrus to Present at the Jefferies 2012 Global Healthcare Conference GlobeNewswire
May 29 $VTUS undervalued stock that can gain upto 200% in a year, great ph3 results announced recently, target 29$ $$ by peterumble
May 24 $VTUS $ARNA - day to buy and hold for gains $$ by peterumble
May 24 $VTUS @peterrumble, do u know anything about SGYP by lwoolf
May 23 $AMRN $CLDX $VTUS 2 out of 3 green..your turn $AMRN by ITradeforMe
May 21 4 Reasons To Buy Ventrus Biosciences
May 17 Ventrus Biosciences (VTUS) Files 949K Common Shelf for Shareholders Street Insider
May 17 VENTRUS BIOSCIENCES INC Financials

Profile

Exchange: NASDAQGM       Sector: Healthcare       Industry: Drug Manufacturers - Major

1 Year Total Return Performance

This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Ventrus Biosciences is down 40.64% over the last year vs S&P 500 Total Return down 0.41%, Keryx Biopharmaceuticals down 67.57%, and Novartis down 15.41%.

  • VTUS Total Returns
  • ^SPXTR Total Returns
  • KERX Total Returns
  • NVS Total Returns

Fundamentals

Fundamental analysis of a business involves analyzing its financial statements and health, its management and competitive advantages. The key financial statements of a company are the income statement, balance sheet and cash flow statement.

Get Quote for

Pro Strategies Featuring VTUS

Did Ventrus Biosciences make it into our Pro Portfolio Strategies?

Start your YCharts Pro membership now to find out.

VTUS Charts

Recent Quotes

Symbol Price Chg Chg % Market Cap
VTUS 9.86 -0.25 -2.47% 125.47M
VTROD 1.30 +0.00 +0.00%
VTR 57.08 -1.74 -2.96% 16.99B
VTNC 6.58 -0.42 -6.00% 114.31M
VTN 15.92 -0.04 -0.25%
VTJ 18.17 +0.07 +0.39%
VTI 65.97 -1.36 -2.02%
VTA 11.52 -0.05 -0.43%
VT 42.65 -0.79 -1.82%
VSTA 2.80 -0.19 -6.35%
You must be signed in to use watchlists.
Sign In or Register
Create Watchlist from Stock Quotes
Close